Creating Safe Biodegradable Photoluminescent Implant Polymers

创造安全的可生物降解的光致发光植入聚合物

• 批准号: 8298146
• 负责人: Jian Yang
• 金额: $ 3.3万
• 依托单位: UNIVERSITY OF TEXAS ARLINGTON
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-11 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8298146
• 关键词: Absorbable Implants; Address; Animals; Area; Biocompatible Materials; Biological; Biological Process; Biological Sciences; Biology; Biosensing Techniques; Cell-Mediated Cytolysis; Cells; Clinical; Custom; Development; Devices; Disease; Drug Delivery Systems; Dyes; Economics; Encapsulated; Evaluation; Fluorescence; Fluorescent Dyes; Growth; Hand; Image; Implant; In Situ; In Vitro; Infiltration; Label; Left; Malignant Neoplasms; Medical; Medical Research; Medicine; Methodology; Methods; Mission; Monitor; Orthopedics; Outcome; Patients; Photobleaching; Polymers; Process; Property; Proteins; Quantum Dots; Research; Resistance; Sampling; Science; Structure; Therapeutic; Time; Tissue Engineering; Tissues; Toxic effect; Treatment Efficacy; Work; base; biodegradable polymer; bioimaging; biomaterial compatibility; cancer cell; cellular imaging; cost; design; imaging probe; implant material; implantable device; in vivo; in vivo regeneration; innovation; interest; malignant breast neoplasm; medical implant; meetings; molecular imaging; mouse model; nanomedicine; nanoparticle; novel; oncology; quantum; scaffold; success; theranostics; tool; uptake

DESCRIPTION (provided by applicant): Biodegradable polymers have been fabricated into various biomedical implants such as drug delivery nanoparticles, tissue engineering scaffolds, and orthopedic devices. Using biodegradable polymers as implant materials is beneficial as the implants may be degraded and cleared by the body once their missions are complete, leaving no foreign materials in the body. On the other hand, florescent labeling and imaging have fueled the significant growth of life science and medical research due to the increasing demands on analyzing biomolecules, tracking biological process, and visualizing diseases and therapeutic efficacy. The most common fluorescent imaging agents include organic dyes, fluorescent proteins and quantum dots (QDs). The discovery of fluorescent QDs has revolutionized the field of molecular imaging, especially in oncology applications. However, progress made in the past has not alleviated much on their high cost and intrinsic toxicity concerns which substantially hinder their clinical use in patients. As alternatives, fluorescent dyes suffer from photobleaching and fluorescent proteins are dim in vivo and hard to manipulate. It is noteworthy that all the above imaging agents are just "imaging agents". They cannot act alone as medical implants to serve as drug delivery vehicles or tissue engineering scaffolds. Combining biomedical implants and imaging agents for drug delivery and tissue engineering has been a significant focus of research in the past few years. For drug delivery, a significant challenge is to develop multifunctional nanoparticles that can be used to track drug delivery processes and determine therapeutic efficiency in real-time. Although conjugating organic dyes to, or encapsulating QDs in, biodegradable polymers was considered as a significant step in addressing above challenges, it does not address the concerns on their toxicity and low dye-to- nanoparticle labeling ratio for in vivo applications. For tissue engineering, obtaining in-situ and real-time information on scaffold degradation and tissue infiltration/regeneration in vivo, without traumatically explanting samples or sacrificing animals, is an unaddressed challenge. Using safe biodegradable implant polymers that intrinsically emit detectable fluorescence in vivo would address the above challenges in drug delivery and tissue engineering, as well as open new windows for other biological and biomedical applications based on fluorescence labeling and imaging. However, such biomaterials have not been available. Therefore, the objectives of the proposed work are to 1) discover novel in-vivo safe, wholly-biodegradable, photoluminescent (implant) polymers (BPLP), without conjugating organic dyes or semiconducting quantum dots (QDs), and 2) to develop biodegradable polymeric "QDs" (BPLP nanoparticles) promising for bioimaging, exemplified by in vivo breast cancer targeting and imaging. The expected outcomes of the proposed work are that we will understand the mechanisms behind the unique photoluminescent properties of BPLPs, and that we will establish a methodology to expand the BPLP into different types of biodegradable implant polymers. We will demonstrate their novelty and utility by developing biodegradable BPLP nanoparticles (biodegradable polymeric "QDs") for cell labeling and imaging applications, exemplified by cancer cell targeting and imaging in vivo. The Impacts of this proposal lie in that: 1) Unveiling the intriguing fluorescence mechanism and the methods necessary for the syntheses of biodegradable photoluminescent polymers will significantly advance biomaterials science; and 2) the development of BPLPs should bring a paradigm shift in the use of biodegradable implant biomaterials in a broad range of biological and biomedical fields including biosensing, cellular imaging, drug delivery, tissue engineering, and theranostic nanomedicine.

描述（由申请人提供）：可生物降解的聚合物已被制造成各种生物医学植入物，例如药物递送纳米粒子、组织工程支架和矫形装置。使用可生物降解的聚合物作为植入材料是有益的，因为一旦完成任务，植入物就可以被身体降解和清除，不会在体内留下任何异物。另一方面，由于对分析生物分子、跟踪生物过程以及可视化疾病和治疗效果的需求不断增加，荧光标记和成像推动了生命科学和医学研究的显着增长。最常见的荧光成像剂包括有机染料、荧光蛋白和量子点 (QD)。荧光量子点的发现彻底改变了分子成像领域，特别是在肿瘤学应用中。然而，过去取得的进展并没有大大缓解其高成本和内在毒性问题，这严重阻碍了它们在患者中的临床使用。作为替代方案，荧光染料会遭受光漂白，而荧光蛋白在体内颜色暗淡且难以操作。值得注意的是，上述显像剂都只是“显像剂”。它们不能单独作为医疗植入物充当药物输送载体或组织工程支架。将生物医学植入物与显像剂相结合用于药物输送和组织工程一直是过去几年研究的重点。对于药物输送，一个重大挑战是开发可用于跟踪药物输送过程并实时确定治疗效率的多功能纳米颗粒。尽管将有机染料与可生物降解聚合物结合或将量子点封装在可生物降解聚合物中被认为是解决上述挑战的重要一步，但它并没有解决体内应用中对其毒性和低染料与纳米颗粒标记比的担忧。对于组织工程来说，在不创伤性地移植样本或处死动物的情况下获得有关支架降解和体内组织浸润/再生的原位实时信息是一个尚未解决的挑战。使用在体内本质上发射可检测荧光的安全的可生物降解植入聚合物将解决药物输送和组织工程中的上述挑战，并为基于荧光标记和成像的其他生物和生物医学应用打开新的窗口。然而，这样的生物材料还没有获得。因此，拟议工作的目标是 1) 发现新型体内安全、完全可生物降解的光致发光（植入）聚合物 (BPLP)，无需共轭有机染料或半导体量子点 (QD)，2) 开发有望用于生物成像的可生物降解聚合物“QD”（BPLP 纳米粒子），例如 体内乳腺癌靶向和成像。拟议工作的预期成果是，我们将了解 BPLP 独特光致发光特性背后的机制，并且我们将建立一种方法将 BPLP 扩展到不同类型的可生物降解植入聚合物。我们将通过开发用于细胞标记和成像应用的可生物降解的 BPLP 纳米颗粒（可生物降解的聚合物“QD”）来展示其新颖性和实用性，例如体内癌细胞靶向和成像。该提案的影响在于：1）揭示有趣的荧光机制和合成可生物降解的光致发光聚合物所需的方法将显着推进生物材料科学； 2）BPLP的发展应该会带来生物可降解植入生物材料在广泛的生物和生物医学领域的使用范式转变，包括生物传感、细胞成像、药物输送、组织工程和治疗诊断纳米医学。